Becton Dickinson and Company 1897

industry:
Manufacturer
Nationality:
American
based:
New Jersey, United States

Based in New Jersey, United States

Related Objects

Box of Soloshot Syringes, 1994

7 'Soloshot' Syringes, Becton Dickinson & Co

Five 'SoloShot' syringes, United States, 1994
BD FACScan flow cytometry analyser, used to sort cells by labelling them with up to three different fluorescent dyes detected by a single laser, made by Becton Dickinson and Company, New Jersey, United States, 1991. During the 1990s the FACScan was the industry-standard commercial cell analyser in research and clinical settings. This machine was used at MRC Mill Hill Laboratory within immunology, virology, and parasitology research and by yeast geneticists.

BD FACScan flow cytometry analyser
Unused boxed Kit type A for the phase 3 Novavax 2019nCoV-302 vaccine trial at Stockport NHS Foundation Trust, Stepping Hill Hospital, including participant self swab sample, in a black bag labelled NVX03446474 and biological substance category B UN3373 packaging, DCG Pathoseal® 95 bag, labelled 19033124, ruler, digital thermometer, model HK-901, made by Dong Guan City Good Health Electronic Technology Co Ltd, blood sampling vacutainer, known as Eclipse™ Blood Collection needle with pre attached holder, ref 368350, made by Beckton, Dickinson and Company, screw top tubes (white capped, labelled N-Protein 1, barcode 1JP29475946; red screw top labelled, N-Protein 2, barcode 1JP25544552, red push top, labelled Draw Tube, labelled N-Protein Coll, barcode 1JP25282506), clear plastic 3 ml pipette, blank study identification card (version 1.0 7 Sept 2020), sticker with PPD, notice “do not mix kits, and 3 requisition and contents sheet, 2020

Kit for phase 3 Novavax 2019nCoV-302 vaccine trial at Stockport NHS Foundation Trust
Box containing 100 B-D `Soloshot' Syringes, made to autodestruct after single use, carrying box converts to sharps box to prevent the spread of AIDS, approved by UNICEF and the World Health Organisation for the use in the Expanded Programme on Immunisation. Manufactured by Becton Dickinson & Co, New Jersey, USA and supplied by the UNICEF Supply Division, Copenhagen, Denmark, 1994

B-D `Soloshot' Syringes
Box containing 100 B-D `Soloshot' Syringes, made to autodestruct after single use, carrying box converts to sharps box to prevent the spread of AIDS, approved by UNICEF and the World Health Organisation for use in the Expanded Programme on Immunisation. Manufacture by Becton Dickinson & Co, New Jersey, USA and supplied by the UNICEF Supply Division, Copenhagen, Denmark, 1994

Soloshot syringes, 1994.
BD Discardit II syringe with needle, 2ml, made by Becton Dickinson S.A., in Spain, reference number 300318, lot number 2010118, date of expiry 2025-09, of the type used during COVID-19 vaccination work at University Hospital Coventry, England, 2020-2021.

BD Discardit II syringe with needle
2 sealed and unusued BD Flu+ syringes for use with the Oxford/AstraZeneca COVID-19 vaccine, ref 305832, expiry date 2025-12-31, made by Becton Dickinson, made in Spain, from the Science Museum NHS COVID-19 vaccination centre, 2021

Syringes for vaccines
DGP Pathoseal 95 biohazard bag numbered 18463607 containing a purple topped BD Vacutainer EDTA (Ethylenediamine tetraacetic acid) Blood Collection Tube which prevents the blood sample from clotting, for blood testing of participants in the Ithe Integrated Network for Surveillance, Trials and Investigation of COVID-19 Transmission (INSTINCT) study, 2020

Blood sampling kit for INSTINCT study
Sealed polythene bag containing blood collection kit, consisting of one BD Vacutainer Eclipse™ blood collection needle reference 368350 made by Becton, Dickinson and Company; one empty tube with a clear cap labelled N-Protein 1 barcode 1JP29475946; one empty tube with a red screw-cap labelled N-Protein 2 barcode 1JP25544552; and one empty tube with red push cap labelled N-Protein Coll barcode 1JP25282506; all from kit for phase 3 Novavax 2019nCoV-302 vaccine trial at Stockport NHS Foundation Trust.

Blood Collection Kit for Phase 3 Novavax 2019nCoV-302 Vaccine Trial

See more related objects